Norman Orentreich

American dermatologist (1922–2019)

Norman Orentreich (December 26, 1922 – January 23, 2019) was a New York dermatologist, a biogerontologist, a foundational innovator in cosmetics, and the father of hair transplantation.²

From Wikipedia’s article on Norman Orentreich (this version), CC BY-SA 4.0.

Born Dec 26, 1922, died Jan 23, 2019.¹

About

Orentreich created Estée Lauder Companies' Clinique line of skin care products, invented a number of dermatologic procedures and was the first president of the American Society for Dermatologic Surgery. He is the founder of the Orentreich Medical Group and the Orentreich Foundation for the Advancement of Science, and the co-director of the latter organization.

From Wikipedia’s article on Norman Orentreich, shared under CC BY-SA 4.0.²

Companies

Clinique Laboratories, LLCFounder¹⁰

Early life and education

Date not recordedGrossman School of Medicine³

Career

Occupation: dermatologist.⁶

Date not recordedWorked at New York University⁴
Date not recordedFounded Clinique Laboratories, LLC⁵

Personal life

BornDec 26, 1922, New York City⁷
DiedJan 23, 2019, New York City⁸
CitizenshipUnited States⁹

Philanthropy

As an undergraduate student, Orentreaich learned of experiments done by Nobel laureate Alexis Carrell that showed that the rate of wound healing declined with age, and that the rate of cell proliferation in tissue culture could be increased by the addition of blood serum from younger donors or decreased using serum from older donors.

In 1961, Orentreich founded the Orentreich Foundation for the Advancement of Science (OFAS), a biomedical research organization. OFAS has done work on the biology of aging, cancer and dermatology. One of his first experiments there was to replicate Carrell's result. He was optimistic for hormone replacement therapy as a means to retard the aging process, and studied th potential role of "metabolic toxins" such as soluble tumor necrosis factor receptor 2 in aging, the role of glucose metabolism in Alzheimer's disease, as well as hyperinsulinemia, methionine restriction, and autoimmune diseases of the skin in aging.

Beginning in 1964, a group of members of the Kaiser Permanente integrated care delivery system in the northern California region participated in a program conducted by Kaiser Permanente that involved broad-spectrum physical examinations, including blood testing. Kaiser Permanente continued to maintain a portion of the blood serum specimens for use in future health research. Starting in 1980 and continuing until 2012, OFAS contributed the resources and services that were required to retain and maintain the KP-OFAS Serum Repository. In particular, OFAS validated the chemical integrity of the retained serum and catalogued the specimens and their coded data in a computer database so they could be retrieved efficiently and used productively in health research studies.

In celebration of the bicentennial of the United States, the Orentreich foundation was called upon to study hairs belonging to President George Washington to determine the blood type of America's first president. After seeking out the assistance and expertise of Dr. M. Mitsuo Yokoyama it was determined that Washington had B type blood.